| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Interleukin-6 | 16 | 2019 | 189 | 4.510 |
Why?
|
| Keratinocytes | 9 | 2019 | 32 | 3.610 |
Why?
|
| Skin | 12 | 2020 | 140 | 3.230 |
Why?
|
| Dermatitis, Contact | 5 | 2019 | 7 | 2.700 |
Why?
|
| Irritants | 4 | 2019 | 7 | 2.620 |
Why?
|
| Receptors, Interleukin-6 | 5 | 2019 | 11 | 2.060 |
Why?
|
| Wound Healing | 7 | 2019 | 113 | 1.380 |
Why?
|
| Dermatitis, Irritant | 2 | 2019 | 2 | 1.080 |
Why?
|
| Fibroblasts | 5 | 2012 | 152 | 1.060 |
Why?
|
| Gene Expression Regulation | 7 | 2019 | 627 | 1.030 |
Why?
|
| Mice | 31 | 2020 | 4399 | 1.020 |
Why?
|
| Animals | 38 | 2020 | 9943 | 0.910 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2017 | 8 | 0.900 |
Why?
|
| Transforming Growth Factor beta | 3 | 2017 | 77 | 0.890 |
Why?
|
| Mice, Inbred C57BL | 22 | 2020 | 1471 | 0.880 |
Why?
|
| Epidermis | 2 | 2019 | 11 | 0.850 |
Why?
|
| Liver | 10 | 2012 | 415 | 0.830 |
Why?
|
| Alcohol Drinking | 7 | 2012 | 162 | 0.780 |
Why?
|
| Cytokines | 10 | 2019 | 439 | 0.740 |
Why?
|
| Petroleum Pollution | 1 | 2020 | 3 | 0.730 |
Why?
|
| Occupational Diseases | 1 | 2020 | 8 | 0.730 |
Why?
|
| Hydrocarbons | 5 | 2019 | 41 | 0.720 |
Why?
|
| Inflammation | 4 | 2019 | 601 | 0.720 |
Why?
|
| Dermatitis | 1 | 2020 | 6 | 0.720 |
Why?
|
| Petroleum | 1 | 2020 | 34 | 0.700 |
Why?
|
| Water Pollutants, Chemical | 1 | 2020 | 50 | 0.700 |
Why?
|
| Receptors, Interleukin | 1 | 2019 | 12 | 0.680 |
Why?
|
| Mice, Knockout | 11 | 2019 | 781 | 0.660 |
Why?
|
| Myeloid Cells | 1 | 2019 | 27 | 0.660 |
Why?
|
| Hyperglycemia | 1 | 2019 | 77 | 0.610 |
Why?
|
| Benzalkonium Compounds | 4 | 2019 | 9 | 0.600 |
Why?
|
| Gene Expression | 3 | 2018 | 406 | 0.570 |
Why?
|
| Phenotype | 1 | 2019 | 664 | 0.550 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 439 | 0.530 |
Why?
|
| Chemokines | 5 | 2019 | 73 | 0.520 |
Why?
|
| Tumor Necrosis Factor-alpha | 10 | 2012 | 243 | 0.520 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 2 | 2012 | 9 | 0.470 |
Why?
|
| I-kappa B Proteins | 2 | 2012 | 11 | 0.430 |
Why?
|
| Disease Models, Animal | 6 | 2019 | 1392 | 0.430 |
Why?
|
| Cells, Cultured | 10 | 2019 | 968 | 0.420 |
Why?
|
| Killer Cells, Natural | 8 | 2000 | 61 | 0.410 |
Why?
|
| I-kappa B Kinase | 1 | 2012 | 8 | 0.410 |
Why?
|
| Dermis | 1 | 2012 | 3 | 0.400 |
Why?
|
| Macrophages | 3 | 2012 | 273 | 0.400 |
Why?
|
| Estrogens | 1 | 2012 | 56 | 0.400 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2012 | 40 | 0.380 |
Why?
|
| Estradiol | 1 | 2012 | 174 | 0.380 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 3 | 2019 | 6 | 0.330 |
Why?
|
| Ethanol | 8 | 2012 | 118 | 0.330 |
Why?
|
| Mice, Inbred BALB C | 2 | 2020 | 263 | 0.320 |
Why?
|
| RNA, Small Interfering | 2 | 2024 | 194 | 0.310 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2007 | 11 | 0.290 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2007 | 9 | 0.290 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2007 | 16 | 0.290 |
Why?
|
| Male | 12 | 2020 | 12854 | 0.280 |
Why?
|
| Cell Movement | 3 | 2007 | 352 | 0.270 |
Why?
|
| Actins | 1 | 2006 | 93 | 0.260 |
Why?
|
| Flow Cytometry | 4 | 2024 | 282 | 0.260 |
Why?
|
| Alcoholism | 4 | 1995 | 116 | 0.250 |
Why?
|
| Cytotoxicity, Immunologic | 3 | 1995 | 26 | 0.250 |
Why?
|
| Immunohistochemistry | 3 | 2019 | 453 | 0.250 |
Why?
|
| RNA, Messenger | 8 | 2012 | 645 | 0.240 |
Why?
|
| Lentivirus | 1 | 2024 | 16 | 0.230 |
Why?
|
| Gene Knockdown Techniques | 1 | 2024 | 131 | 0.220 |
Why?
|
| Phosphorylation | 4 | 2012 | 558 | 0.220 |
Why?
|
| Animals, Newborn | 2 | 2017 | 163 | 0.220 |
Why?
|
| Sex Characteristics | 1 | 2004 | 162 | 0.210 |
Why?
|
| Blotting, Western | 1 | 2024 | 503 | 0.210 |
Why?
|
| Rats | 7 | 2012 | 1544 | 0.200 |
Why?
|
| STAT3 Transcription Factor | 3 | 2012 | 86 | 0.200 |
Why?
|
| Interleukin-2 | 3 | 1996 | 33 | 0.190 |
Why?
|
| Adjuvants, Immunologic | 1 | 2001 | 62 | 0.190 |
Why?
|
| Transcription, Genetic | 3 | 2018 | 399 | 0.190 |
Why?
|
| Skin Irritancy Tests | 1 | 2020 | 4 | 0.180 |
Why?
|
| Occupational Exposure | 1 | 2020 | 25 | 0.180 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 140 | 0.180 |
Why?
|
| Female | 15 | 2020 | 14434 | 0.180 |
Why?
|
| Liver Regeneration | 1 | 2000 | 6 | 0.170 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2000 | 7 | 0.170 |
Why?
|
| Neutrophils | 3 | 2019 | 177 | 0.170 |
Why?
|
| Models, Animal | 1 | 2020 | 129 | 0.170 |
Why?
|
| Signal Transduction | 2 | 2019 | 1338 | 0.170 |
Why?
|
| Rats, Wistar | 3 | 2012 | 145 | 0.170 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 44 | 0.170 |
Why?
|
| Streptozocin | 1 | 2019 | 11 | 0.170 |
Why?
|
| Genotype | 1 | 2020 | 441 | 0.160 |
Why?
|
| CD11 Antigens | 1 | 2019 | 3 | 0.160 |
Why?
|
| Genetic Variation | 1 | 2020 | 229 | 0.160 |
Why?
|
| Cell Division | 6 | 2004 | 153 | 0.160 |
Why?
|
| Coal | 1 | 2018 | 11 | 0.160 |
Why?
|
| Immunity | 1 | 2018 | 26 | 0.160 |
Why?
|
| Kidney | 2 | 2018 | 275 | 0.150 |
Why?
|
| Transforming Growth Factors | 1 | 2017 | 2 | 0.150 |
Why?
|
| Smad7 Protein | 1 | 2017 | 6 | 0.150 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 96 | 0.150 |
Why?
|
| Psoriasis | 1 | 2017 | 6 | 0.150 |
Why?
|
| Monocytes | 1 | 2019 | 131 | 0.150 |
Why?
|
| Glucose | 1 | 2019 | 192 | 0.150 |
Why?
|
| Smad Proteins | 1 | 2017 | 18 | 0.140 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 35 | 0.140 |
Why?
|
| Humans | 10 | 2024 | 26789 | 0.130 |
Why?
|
| Biomarkers | 1 | 2019 | 731 | 0.130 |
Why?
|
| Killer Cells, Lymphokine-Activated | 1 | 1995 | 1 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 322 | 0.120 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 204 | 0.120 |
Why?
|
| Cell Proliferation | 1 | 2017 | 766 | 0.120 |
Why?
|
| Carbon Tetrachloride | 4 | 2001 | 8 | 0.110 |
Why?
|
| Fatty Liver | 2 | 2012 | 49 | 0.110 |
Why?
|
| Mannose-Binding Lectins | 1 | 2012 | 4 | 0.110 |
Why?
|
| Acetone | 1 | 2012 | 6 | 0.110 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 487 | 0.100 |
Why?
|
| Transcription Factor RelA | 1 | 2012 | 21 | 0.100 |
Why?
|
| Lectins, C-Type | 1 | 2012 | 36 | 0.100 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2012 | 2 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 109 | 0.100 |
Why?
|
| Testosterone | 1 | 2012 | 70 | 0.100 |
Why?
|
| Trans-Activators | 2 | 2004 | 113 | 0.100 |
Why?
|
| Cell Line | 3 | 2018 | 672 | 0.100 |
Why?
|
| Dexamethasone | 2 | 2001 | 52 | 0.090 |
Why?
|
| DNA-Binding Proteins | 3 | 2005 | 482 | 0.090 |
Why?
|
| Chemical and Drug Induced Liver Injury | 2 | 2001 | 23 | 0.090 |
Why?
|
| Disease Progression | 1 | 2012 | 450 | 0.090 |
Why?
|
| Administrative Personnel | 1 | 2010 | 6 | 0.090 |
Why?
|
| Social Change | 1 | 2010 | 4 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2004 | 323 | 0.090 |
Why?
|
| Faculty | 1 | 2010 | 61 | 0.090 |
Why?
|
| Adult | 2 | 2020 | 7365 | 0.080 |
Why?
|
| Interleukin-1 | 3 | 2004 | 23 | 0.080 |
Why?
|
| Middle Aged | 1 | 2020 | 6803 | 0.080 |
Why?
|
| Rats, Long-Evans | 2 | 2005 | 35 | 0.080 |
Why?
|
| BCG Vaccine | 1 | 2007 | 13 | 0.070 |
Why?
|
| Cystitis | 1 | 2007 | 11 | 0.070 |
Why?
|
| Granulation Tissue | 1 | 2007 | 7 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2007 | 240 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 3 | 2001 | 18 | 0.070 |
Why?
|
| Melanoma, Experimental | 2 | 2000 | 29 | 0.070 |
Why?
|
| Interleukin-17 | 1 | 2007 | 51 | 0.070 |
Why?
|
| DNA Primers | 2 | 2004 | 143 | 0.070 |
Why?
|
| Urinary Bladder | 1 | 2007 | 118 | 0.070 |
Why?
|
| Janus Kinase 1 | 1 | 2006 | 4 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 86 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2006 | 95 | 0.060 |
Why?
|
| Chemokines, CXC | 1 | 2004 | 12 | 0.060 |
Why?
|
| Neutrophil Infiltration | 1 | 2004 | 19 | 0.060 |
Why?
|
| Organoids | 1 | 2024 | 21 | 0.060 |
Why?
|
| Heart | 1 | 2005 | 219 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 1996 | 407 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 1998 | 623 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2024 | 107 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 83 | 0.060 |
Why?
|
| Transcription Factor AP-1 | 2 | 2000 | 26 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 139 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2000 | 340 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 146 | 0.050 |
Why?
|
| Mice, Inbred C3H | 2 | 2000 | 58 | 0.050 |
Why?
|
| Matrix Metalloproteinase 10 | 1 | 2001 | 1 | 0.050 |
Why?
|
| Injections, Subcutaneous | 1 | 2001 | 58 | 0.050 |
Why?
|
| Metalloendopeptidases | 1 | 2001 | 39 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2001 | 67 | 0.050 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2000 | 4 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2000 | 114 | 0.040 |
Why?
|
| Hepatectomy | 1 | 2000 | 26 | 0.040 |
Why?
|
| Cell Separation | 1 | 2000 | 55 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2000 | 116 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2001 | 240 | 0.040 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 1999 | 5 | 0.040 |
Why?
|
| Spleen | 3 | 1997 | 109 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2018 | 10 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2018 | 29 | 0.040 |
Why?
|
| Mercury | 1 | 2018 | 12 | 0.040 |
Why?
|
| Vanadium Compounds | 1 | 1998 | 1 | 0.040 |
Why?
|
| Cadmium Chloride | 1 | 1998 | 2 | 0.040 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2018 | 54 | 0.040 |
Why?
|
| Metals | 1 | 2018 | 39 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 1998 | 310 | 0.040 |
Why?
|
| Physical Conditioning, Animal | 2 | 1997 | 34 | 0.040 |
Why?
|
| Hepatitis, Animal | 1 | 1997 | 1 | 0.040 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 1997 | 9 | 0.040 |
Why?
|
| Carbon | 1 | 2018 | 93 | 0.040 |
Why?
|
| Water | 1 | 2018 | 131 | 0.040 |
Why?
|
| Physical Exertion | 1 | 1997 | 98 | 0.040 |
Why?
|
| Antibodies | 1 | 1997 | 124 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 1998 | 152 | 0.040 |
Why?
|
| Genes, Immediate-Early | 1 | 1997 | 5 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 1997 | 90 | 0.030 |
Why?
|
| Genes, myc | 1 | 1996 | 9 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1996 | 7 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1996 | 13 | 0.030 |
Why?
|
| Cell Count | 1 | 1996 | 84 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 1995 | 49 | 0.030 |
Why?
|
| Cell Survival | 1 | 1996 | 393 | 0.030 |
Why?
|
| Lymphocyte Cooperation | 1 | 1994 | 1 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1994 | 586 | 0.030 |
Why?
|
| United States | 1 | 2018 | 2029 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 1994 | 274 | 0.030 |
Why?
|
| Apoptosis | 1 | 1996 | 739 | 0.030 |
Why?
|
| Lipopolysaccharides | 2 | 2007 | 152 | 0.030 |
Why?
|
| Alanine Transaminase | 2 | 2001 | 25 | 0.020 |
Why?
|
| Schools, Pharmacy | 1 | 2010 | 22 | 0.020 |
Why?
|
| Aspartate Aminotransferases | 2 | 2001 | 20 | 0.020 |
Why?
|
| Leadership | 1 | 2010 | 49 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2000 | 19 | 0.020 |
Why?
|
| Rats, Inbred F344 | 2 | 1998 | 167 | 0.020 |
Why?
|
| DNA | 2 | 2001 | 364 | 0.020 |
Why?
|
| Administration, Intravesical | 1 | 2007 | 16 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2007 | 28 | 0.020 |
Why?
|
| Granuloma | 1 | 2007 | 17 | 0.020 |
Why?
|
| Organ Size | 2 | 1999 | 83 | 0.020 |
Why?
|
| Rabbits | 2 | 1997 | 272 | 0.020 |
Why?
|
| Body Weight | 2 | 1999 | 246 | 0.020 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2005 | 7 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2005 | 7 | 0.020 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2005 | 12 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2005 | 18 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2005 | 22 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2005 | 118 | 0.020 |
Why?
|
| Physical Endurance | 2 | 1997 | 86 | 0.020 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2005 | 43 | 0.020 |
Why?
|
| Myocardium | 1 | 2005 | 171 | 0.010 |
Why?
|
| Leukocyte Count | 2 | 1994 | 24 | 0.010 |
Why?
|
| Fibrillar Collagens | 1 | 2001 | 6 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2001 | 20 | 0.010 |
Why?
|
| Peroxidase | 1 | 2001 | 37 | 0.010 |
Why?
|
| Keratins | 1 | 2001 | 10 | 0.010 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2001 | 57 | 0.010 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2001 | 12 | 0.010 |
Why?
|
| Random Allocation | 1 | 2001 | 148 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2005 | 511 | 0.010 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2001 | 26 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2001 | 262 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 253 | 0.010 |
Why?
|
| RNA | 1 | 2001 | 105 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2001 | 187 | 0.010 |
Why?
|
| Central Nervous System Depressants | 1 | 2000 | 13 | 0.010 |
Why?
|
| Protein Binding | 1 | 2001 | 631 | 0.010 |
Why?
|
| Necrosis | 1 | 2000 | 81 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 1999 | 117 | 0.010 |
Why?
|
| Leukocytes | 1 | 1999 | 67 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2001 | 394 | 0.010 |
Why?
|
| Interleukin-8 | 1 | 1998 | 43 | 0.010 |
Why?
|
| Chemotaxis | 1 | 1998 | 28 | 0.010 |
Why?
|
| Monokines | 1 | 1997 | 1 | 0.010 |
Why?
|
| Chemotactic Factors | 1 | 1997 | 7 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1997 | 45 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 1997 | 6 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1998 | 139 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1999 | 245 | 0.010 |
Why?
|
| Dietary Fats | 1 | 1997 | 55 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 1563 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1997 | 83 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 1997 | 15 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 1998 | 278 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1997 | 263 | 0.010 |
Why?
|
| Antioxidants | 1 | 1998 | 220 | 0.010 |
Why?
|
| Mutation | 1 | 2000 | 818 | 0.010 |
Why?
|
| Energy Intake | 1 | 1994 | 67 | 0.010 |
Why?
|
| Corticosterone | 1 | 1994 | 33 | 0.010 |
Why?
|
| Eating | 1 | 1994 | 66 | 0.010 |
Why?
|
| Poly I-C | 1 | 1993 | 10 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1993 | 27 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1993 | 56 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1993 | 73 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 1993 | 563 | 0.000 |
Why?
|